Lung cancer is a leading cause of cancer mortality for both men and women. Guidelines for the clinical staging and prognosis of lung cancer are under constant revision due to advancement and generation of new data. At the European Lung Cancer Congress 2024 in Prague, the 9th TNM classification for lung cancer was discussed by Dr. Ramon Rami-Porta from the Hospital Universitari MĂștua Terrassa, Spain.1